Synthesis and biological activity of some derivatives of rifamycin P. 1990

B Cavalleri, and M Turconi, and G Tamborini, and E Occelli, and G Cietto, and R Pallanza, and R Scotti, and M Berti, and G Romanó, and F Parenti
Merrell Dow Research Institute--Lepetit Research Center, Gerenzano, Italy.

A series of derivatives of rifamycin P, an antibiotic produced by fermentation of a mutant strain of Nocardia mediterranea or by chemical modification of rifamycin S, have been prepared. The structures of these compounds were determined by 1H NMR, IR, UV, and LC/MS. Their in vitro and in vivo antibacterial activities in comparison with rifampicin and two other rifamycins under investigation were evaluated. The derivatives were more active than rifamycin P against Mycobacterium avium complex and other slowly and rapidly growing nontuberculous mycobacteria which frequently cause systemic infection in patients with AIDS. 2'-(Diethylamino)rifamycin P (P/DEA) appears suitable for further investigation.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D005260 Female Females
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012294 Rifamycins A group of ANTI-BACTERIAL AGENTS characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known ANTI-BACTERIAL AGENTS. They have been isolated from fermentation broths of Streptomyces mediterranei. Rifamycin,Rifomycin,Rifomycins
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

B Cavalleri, and M Turconi, and G Tamborini, and E Occelli, and G Cietto, and R Pallanza, and R Scotti, and M Berti, and G Romanó, and F Parenti
July 1965, Journal of pharmaceutical sciences,
B Cavalleri, and M Turconi, and G Tamborini, and E Occelli, and G Cietto, and R Pallanza, and R Scotti, and M Berti, and G Romanó, and F Parenti
September 1996, Bollettino chimico farmaceutico,
B Cavalleri, and M Turconi, and G Tamborini, and E Occelli, and G Cietto, and R Pallanza, and R Scotti, and M Berti, and G Romanó, and F Parenti
January 2009, Acta poloniae pharmaceutica,
B Cavalleri, and M Turconi, and G Tamborini, and E Occelli, and G Cietto, and R Pallanza, and R Scotti, and M Berti, and G Romanó, and F Parenti
January 2005, Arzneimittel-Forschung,
B Cavalleri, and M Turconi, and G Tamborini, and E Occelli, and G Cietto, and R Pallanza, and R Scotti, and M Berti, and G Romanó, and F Parenti
September 2020, Acta chimica Slovenica,
B Cavalleri, and M Turconi, and G Tamborini, and E Occelli, and G Cietto, and R Pallanza, and R Scotti, and M Berti, and G Romanó, and F Parenti
January 1988, Il Farmaco; edizione scientifica,
B Cavalleri, and M Turconi, and G Tamborini, and E Occelli, and G Cietto, and R Pallanza, and R Scotti, and M Berti, and G Romanó, and F Parenti
February 1988, Die Pharmazie,
B Cavalleri, and M Turconi, and G Tamborini, and E Occelli, and G Cietto, and R Pallanza, and R Scotti, and M Berti, and G Romanó, and F Parenti
January 1977, Pharmaceutica acta Helvetiae,
B Cavalleri, and M Turconi, and G Tamborini, and E Occelli, and G Cietto, and R Pallanza, and R Scotti, and M Berti, and G Romanó, and F Parenti
December 2018, Acta chimica Slovenica,
B Cavalleri, and M Turconi, and G Tamborini, and E Occelli, and G Cietto, and R Pallanza, and R Scotti, and M Berti, and G Romanó, and F Parenti
January 2014, Bioorganicheskaia khimiia,
Copied contents to your clipboard!